Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Aggressive screening, grading of injury and early initiation of antithrombotic therapy may reduce ...
Humacyte, Inc. has announced that the FDA has granted full approval for SYMVESS, a novel bioengineered human tissue designed for use as a vascular conduit in patients with extremity arterial injuries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results